Zinzani, Pier L : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (244)
Les plus populaires
Liste
- Liste
- Tableau

1

Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma

Eskian, Mahsa, Khorasanizadeh, MirHojjat, Zinzani, Pier L, Rezaei, Nima

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 751 KB

english, 2018

2

Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial

Ruth Pettengell, Bertrand Coiffier, Geetha Narayanan, Fernando Hurtado de Mendoza, Raghunadharao Digumarti, Henry Gomez, Pier Luigi Zinzani, Gary Schiller, David Rizzieri, Giles Boland, Paul Cernohous

Journal:

The Lancet Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 322 KB

english, 2012

3

Index

Derenzini, Enrico, Casadei, Beatrice, Pellegrini, Cinzia, Argnani, Lisa, Pileri, Stefano, Zinzani, Pier Luigi

Journal:

Foot and Ankle Clinics

Année:

2004

Langue:

english

Fichier:

PDF, 148 KB

english, 2004

4

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

Viviani, Simonetta, Zinzani, Pier Luigi, Rambaldi, Alessandro, Brusamolino, Ercole, Levis, Alessandro, Bonfante, Valeria, Vitolo, Umberto, Pulsoni, Alessandro, Liberati, Anna Marina, Specchia, Giorgin

Journal:

Boston Medical and Surgical Journal

Année:

2011

Langue:

english

Fichier:

PDF, 767 KB

english, 2011

5

Safety and efficacy of 90 Yttrium-Ibritumomab-Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study

Ibatici, Adalberto, Pica, Gian Matteo, Nati, Sandro, Vitolo, Umberto, Botto, Barbara, Ciochetto, Chiara, Petrini, Mario, Galimberti, Sara, Ciabatti, Elena, Orciuolo, Enrico, Zinzani, Pier Luigi, Casca

Journal:

British Journal of Haematology

Année:

2014

Langue:

english

Fichier:

PDF, 122 KB

english, 2014

6

Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

Pellegrini, Cinzia, Maglie, Roberto, Argnani, Lisa, Pileri, Stefano, Zinzani, Pier Luigi

Journal:

Hematological Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 112 KB

english, 2014

7

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

Zinzani, Pier Luigi, Rigacci, Luigi, Cox, Maria Cristina, Devizzi, Liliana, Fabbri, Alberto, Zaja, Francesco, Di Rocco, Alice, Rossi, Giuseppe, Storti, Sergio, Fattori, Pier Paolo, Argnani, Lisa, Vito

Journal:

Leukemia and Lymphoma

Année:

2016

Langue:

english

Fichier:

PDF, 733 KB

english, 2016

8

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

Younes, Anas, Santoro, Armando, Shipp, Margaret, Zinzani, Pier Luigi, Timmerman, John M, Ansell, Stephen, Armand, Philippe, Fanale, Michelle, Ratanatharathorn, Voravit, Kuruvilla, John, Cohen, Jonatho

Journal:

The Lancet Oncology

Année:

2016

Langue:

english

Fichier:

PDF, 307 KB

english, 2016

9

Angioimmunoblastic T-Cell Lymphoma

Broccoli, Alessandro, Zinzani, Pier Luigi

Journal:

Hematology/Oncology Clinics of North America

Année:

2017

Langue:

english

Fichier:

PDF, 1.81 MB

english, 2017

10

Safety & tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma

Zinzani, Pier Luigi, Ribrag, Vincent, Moskowitz, Craig H., Michot, Jean-Marie, Kuruvilla, John, Balakumaran, Arun, Zhang, Yayan, Chlosta, Sabine, Shipp, Margaret A., Armand, Philippe

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 821 KB

english, 2017

11

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

Prince, H Miles, Kim, Youn H, Horwitz, Steven M, Dummer, Reinhard, Scarisbrick, Julia, Quaglino, Pietro, Zinzani, Pier Luigi, Wolter, Pascal, Sanches, Jose A, Ortiz-Romero, Pablo L, Akilov, Oleg E, Ge

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 627 KB

english, 2017

12

Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease

Broccoli, Alessandro, Argnani, Lisa, Zinzani, Pier Luigi

Journal:

Cancer Treatment Reviews

Année:

2017

Langue:

english

Fichier:

PDF, 385 KB

english, 2017

13

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Wang, Michael, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Casasnovas, Olivier, Smith, Stephen D, Damaj, Gandhi, Doorduijn, Jeanette, Lamy, Thierry, Morschhauser, Franck, Panizo, Carlos, Shah, Bijal

Journal:

Lancet (London, England)

Année:

2017

Langue:

english

Fichier:

PDF, 976 KB

english, 2017

14

The unique biology and treatment of primary mediastinal B-cell lymphoma

Broccoli, Alessandro, Zinzani, Pier Luigi

Journal:

Best Practice & Research Clinical Haematology

Année:

2018

Langue:

english

Fichier:

PDF, 524 KB

english, 2018

15

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Kim, Youn H, Bagot, Martine, Pinter-Brown, Lauren, Rook, Alain H, Porcu, Pierluigi, Horwitz, Steven M, Whittaker, Sean, Tokura, Yoshiki, Vermeer, Maarten, Zinzani, Pier Luigi, Sokol, Lubomir, Morris,

Journal:

The Lancet Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 444 KB

english, 2018

16

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Younes, Anas, Sehn, Laurie H., Johnson, Peter, Zinzani, Pier Luigi, Hong, Xiaonan, Zhu, Jun, Patti, Caterina, Belada, David, Samoilova, Olga, Suh, Cheolwon, Leppä, Sirpa, Rai, Shinya, Turgut, Mehmet,

Journal:

Journal of Clinical Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 1.19 MB

english, 2019

17

Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma

von Tresckow, Bastian, Fanale, Michelle, Ardeshna, Kirit M., Chen, Robert, Meissner, Julia, Morschhauser, Franck, Moskowitz, Craig, Zinzani, Pier Luigi, Giezek, Hilde, Balakumaran, Arun, Vo, Thao T.,

Journal:

Leukemia and Lymphoma

Année:

2019

Langue:

english

Fichier:

PDF, 1.00 MB

english, 2019

18

Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial

Zanoni, Lucia, Broccoli, Alessandro, Lambertini, Alessandro, Pellegrini, Cinzia, Stefoni, Vittorio, Lodi, Filippo, Fonti, Cristina, Nanni, Cristina, Zinzani, Pier Luigi, Fanti, Stefano

Journal:

European Journal of Nuclear Medicine and Molecular Imaging

Année:

2019

Langue:

english

Fichier:

PDF, 3.58 MB

english, 2019

19

Peripheral T cell lymphomas: from the bench to the clinic

Fiore, Danilo, Cappelli, Luca Vincenzo, Broccoli, Alessandro, Zinzani, Pier Luigi, Chan, Wing C., Inghirami, Giorgio

Journal:

Nature Reviews Cancer

Année:

2020

Fichier:

PDF, 2.48 MB

2020

20

Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study

Michot, Jean-Marie, Bouabdallah, Reda, Vitolo, Umberto, Doorduijn, Jeanette K, Salles, Gilles, Chiappella, Annalisa, Zinzani, Pier Luigi, Bijou, Fontanet, Kersten, Marie JosÃ©, Sarmiento, Rafael, Mosu

Journal:

The Lancet Haematology

Année:

2020

Fichier:

PDF, 434 KB

2020

21

Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure

Roberto Stasi, Pier Luigi Zinzani, Piero Galieni, Vito Michele Lauta, Eugenio Damasio, Egidio Dispensa, Franco Dammacco, Sante Tura, Giuseppe Papa

Journal:

Année:

1994

Langue:

english

Fichier:

PDF, 875 KB

english, 1994

22

Comparison of prognostic models in patients with advanced Hodgkin disease : Promising results from integration of the best three systems

Paolo G. Gobbi, Pier Luigi Zinzani, Chiara Broglia, Mario Comelli, Massimo Magagnoli, Massimo Federico, Francesco Merli, Emilio Iannitto, Sante Tura, Edoardo Ascari

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 195 KB

english, 2001

23

Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of Hematology

Umberto Vitolo, Giovanni Barosi, Stefano Fanti, Alessandro M. Gianni, Maurizio Martelli, Mario Petrini, Pier Luigi Zinzani, Sante Tura

Journal:

American Journal of Hematology

Année:

2010

Langue:

english

Fichier:

PDF, 161 KB

english, 2010

24

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

Pier Luigi Zinzani, Vittorio Stefoni, Gerardo Musuraca, Monica Tani, Lapo Alinari, Annalisa Gabriele, Enrica Marchi, Stefano Pileri, Michele Baccarani

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 76 KB

english, 2004

25

The clinical value of tumor burden at diagnosis in Hodgkin lymphoma

Paolo G. Gobbi, Chiara Broglia, Giuseppe Di Giulio, Monica Mantelli, Paola Anselmo, Francesco Merli, Pier L. Zinzani, Gabriele Rossi, Vincenzo Callea, Emilio Iannitto, Marco Paulli, Lorena Garioni, Ed

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 138 KB

english, 2004

26

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

Pier Luigi Zinzani, Monica Tani, Stefano Fanti, Vittorio Stefoni, Gerardo Musuraca, Umberto Vitolo, Alessio Perrotti, Mariapaola Fina, Enrico Derenzini, Michele Baccarani

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 101 KB

english, 2008

27

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma

Enrico Derenzini, Gerardo Musuraca, Stefano Fanti, Vittorio Stefoni, Monica Tani, Lapo Alinari, Filippo Venturini, Letizia Gandolfi, Michele Baccarani, Pier Luigi Zinzani

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 149 KB

english, 2008

28

Hairy cell leukemia : Evaluation of the long-term outcome in 121 patients

Pier Luigi Zinzani, Cinzia Pellegrini, Vittorio Stefoni, Enrico Derenzini, Letizia Gandolfi, Alessandro Broccoli, Lisa Argnani, Federica Quirini, Stefano Pileri, Michele Baccarani

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 137 KB

english, 2010

29

Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients

Pier Luigi Zinzani, Alessandro Broccoli, Vittorio Stefoni, Gerardo Musuraca, Elisabetta Abruzzese, Amalia De Renzo, Maria Cantonetti, Francesco Bacci, Michele Baccarani, Stefano A. Pileri

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 212 KB

english, 2010

30

Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma

Pier Luigi Zinzani, Letizia Gandolfi, Alessandro Broccoli, Lisa Argnani, Stefano Fanti, Cinzia Pellegrini, Vittorio Stefoni, Enrico Derenzini, Federica Quirini, Michele Baccarani

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 362 KB

english, 2011

31

Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell–like than in germinal center B-cell–like phenotype

Francisco J. Hernandez-Ilizaliturri, George Deeb, Pier L. Zinzani, Stefano A. Pileri, Farhana Malik, William R. Macon, Andre Goy, Thomas E. Witzig, Myron S. Czuczman

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 477 KB

english, 2011

32

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia : An effective but myelosuppressive regimen to be offered to patients with advanced disease

Alessandra Tedeschi, Giulia Benevolo, Marzia Varettoni, Marta L. Battista, Pier L. Zinzani, Carlo Visco, Vittorio Meneghini, Pietro Pioltelli, Stefano Sacchi, Francesca Ricci, Michele Nichelatti, Fran

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 172 KB

english, 2012

33

Mycosis fungoides

Pier Luigi Zinzani, Andrés J.M. Ferreri, Lorenzo Cerroni

Journal:

Critical Reviews in Oncology/Hematology

Année:

2008

Fichier:

PDF, 719 KB

2008

34

Enteropathy-associated T-cell lymphoma

Andrés J.M. Ferreri, Pier Luigi Zinzani, Silvia Govi, Stefano A. Pileri

Journal:

Critical Reviews in Oncology/Hematology

Année:

2011

Langue:

english

Fichier:

PDF, 398 KB

english, 2011

35

Peripheral T-cell lymphoma – Not otherwise specified

Kerry J. Savage, Andrés J.M. Ferreri, Pier Luigi Zinzani, Stefano A. Pileri

Journal:

Critical Reviews in Oncology/Hematology

Année:

2011

Langue:

english

Fichier:

PDF, 400 KB

english, 2011

36

Rituximab in primary conjunctiva lymphoma

Pier Luigi Zinzani, Lapo Alinari, Vittorio Stefoni, Antonio Loffredo, Patrizia Pichierri, Ennio Polito

Journal:

Leukemia Research

Année:

2005

Langue:

english

Fichier:

PDF, 79 KB

english, 2005

37

From chronic lymphocytic leukemia to Hodgkin’s disease: a case of prognostically favorable transformation

Pier Luigi Zinzani, Stefano Ascani, Monica Tani, Vittorio Stefoni, Pier Paolo Piccaluga, Stefano Pileri, Michele Baccarani

Journal:

Leukemia Research

Année:

2002

Langue:

english

Fichier:

PDF, 152 KB

english, 2002

38

Waldenstrom’s macroglobulinemia: is there a place and time for a cease-fire?

Pier Luigi Zinzani, Monica Tani, Lapo Alinari, Vittorio Stefoni, Michele Baccarani

Journal:

Leukemia Research

Année:

2003

Langue:

english

Fichier:

PDF, 119 KB

english, 2003

39

The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies

Sergio Cortelazzo, Andrea Rossi, Elena Oldani, Teresio Motta, Roberto Giardini, Pier Luigi Zinzani, Emanuele Zucca, Henry Gomez, Andrés J.M. Ferreri, Graziella Pinotti, Claudio Chini, Liliana Devizzi,

Journal:

British Journal of Haematology

Année:

2002

Langue:

english

Fichier:

PDF, 280 KB

english, 2002

40

Early interim18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients

Pier Luigi Zinzani, Luigi Rigacci, Vittorio Stefoni, Alessandro Broccoli, Benedetta Puccini, Antonio Castagnoli, Luca Vaggelli, Lucia Zanoni, Lisa Argnani, Michele Baccarani, Stefano Fanti

Journal:

European Journal of Nuclear Medicine and Molecular Imaging

Année:

2012

Langue:

english

Fichier:

PDF, 297 KB

english, 2012

41

CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission

Vittorio Stefoni, Alessandro Broccoli, Cinzia Pellegrini, Enrico Derenzini, Mariapaola Fina, Pier Luigi Zinzani

Journal:

Journal of Neuro-Oncology

Année:

2009

Langue:

english

Fichier:

PDF, 212 KB

english, 2009

42

PET in T-Cell Lymphoma

Pier Luigi Zinzani

Journal:

Current Hematologic Malignancy Reports

Année:

2011

Langue:

english

Fichier:

PDF, 92 KB

english, 2011

43

Primary Mediastinal DLBCL: Evolving Biologic Understanding and Therapeutic Strategies

Pier Luigi Zinzani, Pier Paolo Piccaluga

Journal:

Current Oncology Reports

Année:

2011

Langue:

english

Fichier:

PDF, 183 KB

english, 2011

44

Early relapse in a patient with Hodgkin’s disease and negative interim FDG-PET

Stefano Fanti, Paolo Castellucci, Vittorio Stefoni, Cristina Nanni, Monica Tani, Domenico Rubello, Valentina Ambrosini, Pier Luigi Zinzani, Roberto Franchi

Journal:

Annals of Nuclear Medicine

Année:

2008

Langue:

english

Fichier:

PDF, 200 KB

english, 2008

45

Complications of cytotoxic chemotherapy in older patients: focus on myelotoxicity in lymphomas

Pier Luigi Zinzani

Journal:

Critical Reviews in Oncology/Hematology

Année:

2003

Langue:

english

Fichier:

PDF, 68 KB

english, 2003

46

Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization

Francesco Crea, Elisa Giovannetti, Pier Luigi Zinzani, Romano Danesi

Journal:

Critical Reviews in Oncology/Hematology

Année:

2009

Langue:

english

Fichier:

PDF, 722 KB

english, 2009

47

Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion

Pier Paolo Piccaluga, Ernesto Vigna, Angelo Placci, Claudio Agostinelli, Claudio Laterza, Cristina Papayannidis, Ornella Leone, Giovanni Martinelli, Pier Luigi Zinzani, Michele Baccarani, Stefano A. P

Journal:

British Journal of Haematology

Année:

2006

Langue:

english

Fichier:

PDF, 109 KB

english, 2006

48

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin

Myron S. Czuczman, Julie M. Vose, Thomas E. Witzig, Pier L. Zinzani, Rena Buckstein, Jonathan Polikoff, Ju Li, Dennis Pietronigro, Annetti Ervin-Haynes, Craig B. Reeder

Journal:

British Journal of Haematology

Année:

2011

Langue:

english

Fichier:

PDF, 109 KB

english, 2011

49

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin’s lymphoma patients

Rigacci, Luigi, Puccini, Benedetta, Cortelazzo, Sergio, Gaidano, Gianluca, Piccin, Andrea, D’Arco, Alfonso, Freilone, Roberto, Storti, Sergio, Orciuolo, Enrico, Zinzani, Pier Luigi, Zaja, Francesco, B

Journal:

Annals of Hematology

Année:

2012

Langue:

english

Fichier:

PDF, 317 KB

english, 2012

50

FDG PET/CT predictive role in follicular lymphoma

Egesta Lopci, Lucia Zanoni, Arturo Chiti, Cristina Fonti, Ivan Santi, Pier Luigi Zinzani, Stefano Fanti

Journal:

European Journal of Nuclear Medicine and Molecular Imaging

Année:

2012

Langue:

english

Fichier:

PDF, 361 KB

english, 2012